Vortrag am FONDS professionell KONGRESSJPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity (ESG) UCITS ETF - USD (acc)
| MVD-Fonds Rating | EDA |
|---|---|
 | 72 |
ISIN: IE00BF4G6Y48 | WKN: A2DWM6
KAG: JPMorgan AM (EU)
NAV: 49,41 USD am 19.08.2024
Portfolio
Watchlist
KursalarmChart
Kennzahlen JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity (ESG) UCITS ETF - USD (acc)
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +1,92% | +11,44% | +27,17% | +27,97% | +94,76% | - | +103,08% |
| Volatilität | +20,07% | +11,54% | +10,94% | +15,02% | +17,90% | - | +17,26% |
| Sharpe Ratio | +1,07 | +1,79 | +2,17 | +0,33 | +0,60 | - | +0,54 |
| Bester Monat | - | +4,58% | +9,42% | +9,42% | +12,58% | - | +12,58% |
| Schl. Monat | - | -3,37% | -4,30% | -8,92% | -13,02% | - | -13,02% |
| Max. Verlust | -6,66% | -8,18% | -8,44% | -25,47% | -33,95% | - | -33,95% |
Monatsperformance JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity (ESG) UCITS ETF - USD (acc)
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Januar | +1,40% | +7,32% | -5,12% | -0,96% | -0,70% |
| Februar | +4,50% | -2,28% | -2,71% | +2,74% | -8,32% |
| März | +3,13% | +3,09% | +2,60% | +3,88% | -13,02% |
| April | -3,37% | +1,96% | -8,07% | +4,56% | +11,02% |
| Mai | +4,58% | -0,71% | +0,17% | +1,55% | +4,96% |
| Juni | +2,02% | +6,08% | -8,63% | +1,42% | +3,01% |
| Juli | +1,53% | +3,25% | +8,22% | +1,90% | +4,85% |
| August | +1,47% | -2,07% | -4,22% | +2,57% | +7,13% |
| September | - | -4,30% | -8,92% | -4,35% | -3,49% |
| Oktober | - | -2,75% | +6,96% | +6,03% | -3,11% |
| November | - | +9,42% | +7,27% | -1,77% | +12,58% |
| Dezember | - | +4,80% | -4,43% | +4,62% | +3,98% |
| Gesamt | +16,07% | +25,29% | -17,51% | +24,00% | +16,87% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity (ESG) UCITS ETF) oder suchen Sie weitere Top-Fonds zum Thema Aktien (ETF Aktien) weltweit in USD:
Fonds vergleichenWeitere ähnliche Fonds